Auto & Transportation

Home > News > Auto & Transportation

Chinese cars are more popular in Peru and are expected to win a quarter of the car market by the end

2021-05-19

"Peru 21" reported on March 26 that data from the Peru Automobile Association showed that although the sales of Chinese brands were reduced by the epidemic last year, the decline was smaller than the overall decline in the market. Some Chinese brands even grew against the trend, such as Jinbei (186%). ), Foton (1.8%) and Geely (18%).


Different from other brands, the new crown epidemic is conducive to the advantage of Chinese cars in the secret market to a certain extent, mainly because their prices are lower than traditional brands.


Geely Automobile Peru General Manager Vivas said that in the face of an uncertain future, Peruvian consumers are more cautious in choosing and value functionality. Therefore, Chinese cars will win a larger market in Peru, and 2021 will be no exception.


Chinese brands accounted for 15.8% of the Secret car market in 2018 and increased to 22% in 2020. It is expected to reach 24%-25% by the end of 2021. At the same time, price is no longer the only significant advantage of Chinese brands, and its technology research and development design has also made Chinese cars more popular. Wei said that although Chinese cars are not well-known, they are almost comparable to traditional brands in performance, and their production and innovation capabilities are more dynamic than those of Europe and the United States.


China has become the world's largest automobile producer and has the ability to become a major exporter. According to the Spanish "Expansión" magazine, one-third of the 74 million cars produced worldwide last year were made in China. As far as Peru is concerned, Changan is the best-selling Chinese car, with 4164 vehicles sold last year, followed by JAC (3116), Dongfeng Xiaokang (2928), Great Wall (2006), Chery (1847), Jinbei ( 1021 vehicles), Foton (1004 vehicles) and Geely (622 vehicles).


DISCLAIMER: All information provided by HMEonline is for reference only. None of these views represents the position of HMEonline, and HMEonline makes no guarantee or commitment to it. If you find any works that infringe your intellectual property rights in the article, please contact us and we will modify or delete them in time.
© 2022 Company, Inc. All rights reserved.
WhatsApp